HPV types 16, 18 (DNA qualitative genotyping, swab/F)

We remind you that independent interpretation of the results is unacceptable, the information provided below is for reference purposes only.

Human papillomavirus (HPV) types 16 and 18 genotyping is a PCR-based molecular test used to detect high-risk HPV DNA in urogenital samples. These types are most commonly associated with precancerous lesions and cervical cancer, making their detection highly important for screening and prevention.

Indications

• Routine screening for high-risk HPV
• Abnormal cervical cytology results
• Cervical erosion or dysplasia
• Post-treatment monitoring of HPV infection
• Pregnancy planning
• Infertility evaluation
• Contact with an HPV-positive partner

Procedure

• Collection of cervical and/or endocervical swab
• Performed by a gynecologist
• Takes a few minutes
• Minimal discomfort

Method of testing

The test is performed using PCR, which qualitatively detects HPV DNA types 16 and 18. The method is highly sensitive and allows detection even at low viral loads.
 

Sources:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373819/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077029/
https://www.sciencedirect.com/topics/medicine-and-dentistry/human-papillomavirus-type-18
https://jamanetwork.com/journals/jama/fullarticle/208418

IMPORTANT!

It is crucial to remember that the information provided here is not intended for self-diagnosis or self-treatment. If you experience pain or an exacerbation of a condition, it is essential to consult a healthcare professional for diagnostic tests and appropriate treatment. Only a qualified specialist can make an accurate diagnosis and determine the appropriate treatment plan. To obtain the most accurate and consistent evaluation of test results, it is recommended to conduct them at the same laboratory. Different laboratories may use varying methods and units of measurement for similar tests.